Alphamab Oncology (Stock code: 9966.HK) is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization of world-class innovative therapeutics for cancer treatment. With multiple in-house proprietary platforms in bispecifics, protein engineering and antibody screening, Alphamab Oncology has built a robust pipeline in oncology/ immunology, and we are striving to develop next-generation or best-in-class medicines to address unmet medical needs globally.
View Top Employees from Alphamab OncologyWebsite | http://www.alphamabonc.com |
Employees | 24 (16 on RocketReach) |
Founded | 2015 |
Phone | +86 512 6285 0800 |
Technologies |
JavaScript,
HTML,
PHP
+2 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Biotechnology, Science and Engineering, Clinical Trials, Health Care, Pharmaceutical |
Looking for a particular Alphamab Oncology employee's phone or email?
Yi Xia is the Vice President, Head of Biostatistics and Data Management of Alphamab Oncology.
16 people are employed at Alphamab Oncology.